Evidence map›Paper›PMID 39224682›Full record

ArticleIJU case reports2024

Primary squamous cell carcinoma of the kidney with hepatic invasion.

Masato Takanashi, Miho Asaoka, Masashi Imano, Azumi Fujioka, Yuka Oishi, Goro Matsuda, Sawako Chiba, Kotaro Hirai

Abstract readCase Reports
In one paragraph

Article in IJU case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Masato TakanashiDepartment of Urology National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.ORCID https://orcid.org/0009-0001-0116-3624
Miho AsaokaDepartment of Urology National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.
Masashi ImanoDepartment of Urology National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.
Azumi FujiokaDepartment of Urology National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.
Yuka OishiDepartment of Surgery National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.
Goro MatsudaDepartment of Surgery National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.
Sawako ChibaDepartment of Diagnostic Pathology National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.
Kotaro HiraiDepartment of Urology National Hospital Organization Yokohama Medical Center Yokohama Kanagawa Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Primary squamous cell carcinoma of the kidney is rare, with only a few cases reported to date. Case presentation: A right renal mass was detected in a 73-year-old asymptomatic man. Dynamic contrast-enhanced computed tomography showed a hypodensity mass extending from the upper pole of the kidney to the right lobe of the liver. Renal biopsy revealed that this tumor was squamous cell carcinoma. One month later, computed tomography showed rapid tumor growth. Radical nephrectomy and partial hepatic resection were performed. Pathological analysis indicated that this tumor originated from the tubular epithelium, and the patient was diagnosed with primary squamous cell carcinoma of the kidney.Following up without adjuvant therapy, he developed retroperitoneal recurrence and multiple lung metastases and expired. Conclusion: In this case, squamous cell carcinoma of the kidney invaded the liver and progressed rapidly. Considering these observations, surgical resection should be promptly performed in suspected cases.

Indexed as

hepatectomykidneylivernephrectomysquamous cell carcinoma

Identifiers

PMID39224682
PMCPMC11366424

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.